NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hanall Biopharma (KO: 009420)

 
009420 Technical Analysis
5
As on 16th Dec 2025 009420 STOCK Price closed @ 43500.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 32062.66 & Strong Buy for SHORT-TERM with Stoploss of 37925.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

009420STOCK Price

Open 44600.00 Change Price %
High 45000.00 1 Day -800.00 -1.81
Low 43300.00 1 Week -7600.00 -14.87
Close 43500.00 1 Month 2150.00 5.20
Volume 688261 1 Year 6150.00 16.47
52 Week High 56000.00 | 52 Week Low 24250.00
 
KO Korea Most Active Stocks
093230 33.00 -49.23%
093230 33.00 -49.23%
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
093240 1285.00 -6.00%
093240 1285.00 -6.00%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
005965 26000.00 30.00%
005965 26000.00 30.00%
002995 29700.00 29.98%
002995 29700.00 29.98%
002995 29700.00 29.98%
084670 102800.00 29.96%
084670 102800.00 29.96%
168490 159.00 29.27%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
093230 33.00 -49.23%
001745 3600.00 -46.27%
 
 
009420
Daily Charts
009420
Intraday Charts
Whats New @
Bazaartrend
009420
Free Analysis
 
009420 Important Levels Intraday
RESISTANCE46775.90
RESISTANCE45725.30
RESISTANCE45075.90
RESISTANCE44426.50
SUPPORT42573.50
SUPPORT41924.10
SUPPORT41274.70
SUPPORT40224.10
 
009420 Forecast December 2025
4th UP Forecast70092.6
3rd UP Forecast61564.2
2nd UP Forecast56292.6
1st UP Forecast51021
1st DOWN Forecast35979
2nd DOWN Forecast30707.4
3rd DOWN Forecast25435.8
4th DOWN Forecast16907.4
 
009420 Weekly Forecast
4th UP Forecast55062.00
3rd UP Forecast51354.00
2nd UP Forecast49062.00
1st UP Forecast46770.00
1st DOWN Forecast40230.00
2nd DOWN Forecast37938.00
3rd DOWN Forecast35646.00
4th DOWN Forecast31938.00
 
009420 Forecast2025
4th UP Forecast107284
3rd UP Forecast86827.9
2nd UP Forecast74183.7
1st UP Forecast61539.5
1st DOWN Forecast25460.5
2nd DOWN Forecast12816.3
3rd DOWN Forecast172.1
4th DOWN Forecast-20283.7
 
 
009420 Other Details
Segment EQ
Market Capital 1070211661824.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
009420 Address
009420
 
009420 Latest News
 
Your Comments and Response on Hanall Biopharma
 
009420 Business Profile
Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea. Address: Daewoong Building, Seoul, South Korea
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service